20 May 2013
Keywords: conor, licenses, pimecrolimus, novartis, firm, medsystems, says
Article | 20 March 2006
US firm Conor Medsystems says it has exercised its option to obtain a worldwide, non-exclusive license from Novartis to pimecrolimus ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 March 2006
17 May 2013
© 2013 thepharmaletter.com